A perspective on the selection of unrelated donors and cord blood units for transplantation
- 12 July 2012
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 120 (2) , 259-265
- https://doi.org/10.1182/blood-2012-03-379032
Abstract
Selection of a suitable graft for allogeneic hematopoietic stem cell transplantation involves consideration of both donor and recipient characteristics. Of primary importance is sufficient donor-recipient HLA matching to ensure engraftment and acceptable rates of GVHD. In this Perspective, the National Marrow Donor Program and the Center for International Blood and Marrow Transplant Research provide guidelines, based on large studies correlating graft characteristics with clinical transplantation outcomes, on appropriate typing strategies and matching criteria for unrelated adult donor and cord blood graft selection.This publication has 50 references indexed in Scilit:
- Scoring HLA Class I Mismatches by HistoCheck Does Not Predict Clinical Outcome in Unrelated Hematopoietic Stem Cell TransplantationTransplantation and Cellular Therapy, 2012
- Donor Registries and Search StrategiesPublished by Springer Nature ,2012
- Effect of donor–recipient HLA matching at HLA A, B, C, and DRB1 on outcomes after umbilical-cord blood transplantation for leukaemia and myelodysplastic syndrome: a retrospective analysisThe Lancet Oncology, 2011
- HLA-C Antigen Mismatch Is Associated with Worse Outcome in Unrelated Donor Peripheral Blood Stem Cell TransplantationTransplantation and Cellular Therapy, 2010
- Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysisThe Lancet Oncology, 2010
- Factors affecting mortality following myeloablative cord blood transplantation in adults: a pooled analysis of three international registriesBone Marrow Transplantation, 2010
- HLA-A Disparities Illustrate Challenges for Ranking the Impact of HLA Mismatches on Bone Marrow Transplant Outcomes in the United StatesTransplantation and Cellular Therapy, 2009
- Optimal HLA matching in hematopoietic cell transplantationCurrent Opinion in Immunology, 2008
- Use of natural killer cells as immunotherapy for leukaemiaBest Practice & Research Clinical Haematology, 2008
- HLAMatchmaker-Defined Triplet Matching Is Not Associated with Better Survival Rates of Patients with Class I HLA Allele Mismatched Hematopoietic Cell Transplants from Unrelated DonorsTransplantation and Cellular Therapy, 2008